Institutional Biosafety Committee (IBC)
The Institutional Biosafety Committee (IBC) is the administrative and decision-making body having responsibility for review and approval of research involving recombinant DNA. Before any research involving recombinant DNA can be initiated it must have received IBC review and approval. The activities of the IBC are administered by the Office of Research Compliance (ORC).
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules ("NIH Guidelines")
Institutional Biosafety Committee Guidance
IBC Forms for Download
BGSU IBC Guidelines
IBC Application Form (Revised April, 2020)
IBC Continuing Review Form (Revised April, 2020)
Biosafety Level 1 Requirements
Biosafety Level 2 Requirements
Who can I contact if I have a question about research involving recombinant DNA?
Updated: 03/15/2022 10:02AM